These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 32179240)
21. From Mucuna Pruriens to deep brain stimulation: A two-decade case history. Margolesky J; Shpiner DS; Moore H; Singer C; Jagid J; Luca CC Parkinsonism Relat Disord; 2020 Aug; 77():26-27. PubMed ID: 32604054 [No Abstract] [Full Text] [Related]
23. Effect of antiparkinson drug HP-200 (Mucuna pruriens) on the central monoaminergic neurotransmitters. Manyam BV; Dhanasekaran M; Hare TA Phytother Res; 2004 Feb; 18(2):97-101. PubMed ID: 15022157 [TBL] [Abstract][Full Text] [Related]
24. Poisoning After Ingestion of Mucuna pruriens Seeds on Reunion Island. Maillot A; Schmitt C; Marteau A Wilderness Environ Med; 2022 Mar; 33(1):122-124. PubMed ID: 34895813 [TBL] [Abstract][Full Text] [Related]
25. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling. Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634 [TBL] [Abstract][Full Text] [Related]
26. [Levodopa for Parkinson's disease: What have we learned?]. Juri C C; Chaná C P Rev Med Chil; 2006 Jul; 134(7):893-901. PubMed ID: 17130974 [TBL] [Abstract][Full Text] [Related]
27. An alternative medicine treatment for Parkinson's disease: results of a multicenter clinical trial. HP-200 in Parkinson's Disease Study Group. J Altern Complement Med; 1995; 1(3):249-55. PubMed ID: 9395621 [TBL] [Abstract][Full Text] [Related]
28. Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa. Cilia R; Cereda E; Akpalu A; Sarfo FS; Cham M; Laryea R; Obese V; Oppon K; Del Sorbo F; Bonvegna S; Zecchinelli AL; Pezzoli G Brain; 2020 Aug; 143(8):2490-2501. PubMed ID: 32844196 [TBL] [Abstract][Full Text] [Related]
29. Quantitative NMR analysis of L-Dopa in seeds from two varieties of Mucuna pruriens. Fernandez-Pastor I; Luque-Muñoz A; Rivas F; Medina-O'Donnell M; Martinez A; Gonzalez-Maldonado R; Haidour A; Parra A Phytochem Anal; 2019 Jan; 30(1):89-94. PubMed ID: 30216583 [TBL] [Abstract][Full Text] [Related]
35. Initiation of pharmacological therapy in Parkinson's disease: when, why, and how. de Bie RMA; Clarke CE; Espay AJ; Fox SH; Lang AE Lancet Neurol; 2020 May; 19(5):452-461. PubMed ID: 32171387 [TBL] [Abstract][Full Text] [Related]
36. [Benefits of the combination of mucuna, green tea and levodopa/benserazide in Parkinson's disease]. Gonzalez-Maldonado R; Gonzalez-Redondo R; Di Caudo C Rev Neurol; 2016 Jun; 62(11):524-6. PubMed ID: 27222087 [No Abstract] [Full Text] [Related]
37. Case of levodopa toxicity from ingestion of Mucuna gigantea. Tse GG; Kim BB; McMurtray AM; Nakamoto BK Hawaii J Med Public Health; 2013 May; 72(5):157-60. PubMed ID: 23795319 [TBL] [Abstract][Full Text] [Related]
38. Antiparkinson drug--Mucuna pruriens shows antioxidant and metal chelating activity. Dhanasekaran M; Tharakan B; Manyam BV Phytother Res; 2008 Jan; 22(1):6-11. PubMed ID: 18064727 [TBL] [Abstract][Full Text] [Related]